WeissmannS, BabyevAS, GordonM, et al.Hematological markers in children and adults with atopic dermatitis: A retrospective cohort study. Dermatology, 2024; 240(4):597–605; doi: 10.1159/000539365
2.
ZhangL, PiJ, WangJ, et al.The Association of Inflammatory Indexes derived from peripheral blood cell count and clinical signs with response to treatment with dupilumab in pediatric patients with moderate-to-severe atopic dermatitis. J Inflamm Res, 2025; 18:271–282; doi: 10.2147/jir.S501883
3.
HaginoT, SaekiH, FujimotoE, et al.Predictive factors for primary and secondary nonresponders to upadacitinib in patients with moderate-to-severe atopic dermatitis: A real-world study. Dermatitis, 2024; doi: 10.1089/derm.2024.0445
4.
HaginoT, SaekiH, FujimotoE, et al.Clinical and laboratory indexes for predicting early and late responders to Lebrikizumab in atopic dermatitis: A prospective cohort observational study. Dermatitis, 2025; doi: 10.1089/derm.2025.0118
5.
HaginoT, OndaM, SaekiH, et al.Effects of tralokinumab on clinical and laboratory indexes in atopic dermatitis: A 24-week real-world study. Dermatitis, 2025; 36(3):235–243; doi: 10.1089/derm.2024.0323
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
